The Board of Directors of Fresenius Kabi Pharmaceuticals Holding Inc. (APCVZ), the parent company of APP Pharma Inc., announced that Thomas Silberg, president and chief executive officer of APP, will retire effective December 31, 2009.
John Ducker, a member of the management board of Fresenius Kabi AG responsible for the Fresenius Kabi Innovation Centre, was named by the board as president and chief executive officer.
Under a succession plan, Tom will serve as a consultant for one year to ensure a smooth transition as Ducker assumes his new responsibilities.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.